drugset / Trial / NCT00261586

A Safety Trial to Compare Different Analgesics in Combination With Low Dose Aspirin to Study Their Bleeding Properties and Their Effects on the Stomach

NCT00261586 ↗

RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to compare several analgesics given in approved daily doses in combination with a daily cardioprotective dose of aspirin (81 mg), to study their bleeding properties and their effects on the stomach in healthy volunteers.

Timeline

Start
—
Primary completion
—
Completion
2004-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Acetaminophen Small molecule 1000 mg —
Subject Aspirin Small molecule 81 mg —
Subject Aspirin Small molecule 650 mg —
Subject Celecoxib Other / unclassified 200 mg —
Subject Ibuprofen Small molecule 400 mg —
Subject Naproxen Small molecule 220 mg —
Subject Naproxen Small molecule 440 mg —
Subject rofecoxib Small molecule 25 mg —

Indications

No indication recorded.